SCHEMBL17984973

SCHEMBL17984973

CN(C)C(=O)CNCc1cc(C=NCCC2CCCCC2)ccn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM5B Q9UGL1 12/20 0.39
▸ KDM5C P41229 7/20 0.39
▸ KDM5A P29375 6/20 0.39
▸ HPGD P15428 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ KDM4A O75164 2/20 0.38
▸ KDM6B O15054 1/20 0.38
▸ KDM2B Q8NHM5 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ KDM4C Q9H3R0 2/20 0.37
▸ KDM5D Q9BY66 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ BMP1 P13497 2/20 0.34
▸ MMP2 P08253 1/20 0.34
▸ HTR5A P47898 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16303334 1.00 KDM5B (0.39) KDM5BKDM5CKDM5AHPGDMEN1
SCHEMBL15994335 0.91 KDM5B (0.45) KDM5BKDM5CKDM5AHPGDMEN1
SCHEMBL15994337 0.91 KDM5B (0.45) KDM5BKDM5CKDM5AHPGDMEN1
SCHEMBL16292796 0.89 KDM5B (0.55) KDM5BKDM5CKDM5AHPGDMEN1
SCHEMBL16006901 0.89 KDM5B (0.55) KDM5BKDM5CKDM5AHPGDMEN1
SCHEMBL20041970 0.81 HPGD (0.34) HPGDMEN1KMT2ARECQLNPC1
SCHEMBL16305495 0.81 KDM5B (0.43) KDM5BKDM5CKDM5AKDM4AKDM6B
SCHEMBL20041897 0.80 KDM5B (0.43) KDM5BKDM5CKDM5AHPGDKDM4A
SCHEMBL16303314 0.78 KDM5B (0.46) KDM5BKDM5CKDM5AKDM4AKDM6B
SCHEMBL15994218 0.78 KDM5B (0.46) KDM5BKDM5CKDM5AKDM4AKDM6B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2961736-B1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES INC (US) 2018-04-11 — — EP claimed
US-9650339-B2 Inhibitors of histone demethylases GILEAD SCIENCES, INC. (US) 2017-05-16 — — US claimed
EP-2961736-B1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES INC (US) 2018-04-11 — — EP disclosed
EP-3170811-A1 ETHYL PYRIDINE-4-CARBOXYLATE COMPOUND AS INHIBITOR OF HISTONE DEMETHYLASES Gilead Sciences, Inc. (US) 2017-05-24 — — EP disclosed
US-9650339-B2 Inhibitors of histone demethylases GILEAD SCIENCES, INC. (US) 2017-05-16 — — US disclosed
US-20160237037-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2016-08-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160237037-A1 INHIBITORS OF HISTONE DEMETHYLASES KDM1B, KDM1A, KDM3A KDM5B 27/4885KDM5C 16/4885KDM5A 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback